|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 401 Ninth Street NW, Suite 900 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 27057-12
|
||||||||
|
6. House ID# 302500000
|
TYPE OF REPORT | 8. Year | 2021 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Beth Feldpush |
Date | 10/20/2021 3:33:19 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
oIssues related to Medicaid disproportionate share hospital (DSH) funding and payment
oIssues related to Medicaid funding
oIssues related to Medicaid coverage
oIssues related to Medicare payment
oIssues related to Medicare quality measures
oHR 315 - Medicare Sequester Moratorium Act
oS. 439 - Coronavirus Medicaid Response Act
oS. 646 - Stabilize Medicaid and CHIP Coverage Act
oMedicaid Federal Medical Assistance Percentage (FMAP)
oS. 834 - Resident Physician Shortage Reduction Act of 2021
oIssues related to the Medicare Accelerated and Advance Payment (AAP) programs
oS.368/H.R.1332 - Telehealth Modernization Act
oS. 245 - States Achieve Medicaid Expansion Act
oS. 408 - Supporting Best Practices for Healthy Moms Act
oS. 1512 - CONNECT for Health Act
oS. 1988 - Protecting Rural Telehealth Access Act
oSenate Resolution declaring racism a public health crisis
oMedicaid and CHIP Payment and Access Commission (MACPAC)
oIssues related to graduate medical education
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Beth |
Feldpush |
|
|
|
Carlos |
Jackson |
|
|
|
Margaret |
Peterson |
|
|
|
Carla "Nikki" |
Hurt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
oIssues related to 340B drug pricing program
oCOVID-19 liability protection
oSkilled immigration/employment visas
oIssues related to telehealth
oIssues related to disparities in health and health care
oIssues related to maternal health
oIssues related to social determinants of health and structural racism
oHR 959 - Black Maternal Health Momnibus Act
oHR 950/S. 334 - IMPACT to Save Moms Act
oHR 379/S. 104 - Improving Social Determinants of Health Act
oHR 2054 - No Surprise for New Moms Act
oHR 526 - Ensuring Coverage in Public Health Emergencies Act
oHR 736 - Community Immunity During COVID-19 Act
oHR 853 - Closing orphan drug loophole in 340B
oHR 786 - Supporting State and Local Leaders Act
oHR 2503 - Social Determinants of Health Accelerator Act
oS. 1675/HR 4387 - Maternal Health Quality Improvement Act
oHR 4390 - Equitable treatment for covered entities in 340B
oHR 3746 - Accountable Care in Rural America Act
oValue in Health Care Act
oIssues related to 340B contract pharmacies and third-party vendors
oIssues related to prescription drug prices
oH.R. 5035 - Child Suicide Prevention and Lethal Means Safety Act
oIssues related to the provider relief fund
oIssues related to developing and sustaining the health care work force
oH.R. 4390 - PROTECT 340B Act
oIssues related to behavioral and mental health care
oIssues related to a public health insurance option
oDr. Lorna Breen Health Care Provider Protection Act
oHealthcare Workforce Resilience Act
oConrad State 30 and Physician Access Reauthorization Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Beth |
Feldpush |
|
|
|
Carlos |
Jackson |
|
|
|
Margaret |
Peterson |
|
|
|
Carla "Nikki" |
Hurt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
oConsolidated Appropriations Act, 2021 (H.R. 133)
oH.R.1868 - To prevent across-the-board direct spending cuts, and for other purposes
oCOVID-19 Provider Relief Fund
oHR 1848 - LIFT America Act
oHR 1846 - Hospital construction
oH.R.1319 - American Rescue Plan Act of 2021
oHRSA Title VII and Title VIII programs in the FY 2022 Labor, Health and Human Services, Education and Related Agencies Appropriations
oCDC funding for social determinants of health
oIssues related to hospital and public health infrastructure
oH.R. 5376 - Build Back Better Act
oH.R. 4735/S.2493 Provider Relief Deadline Extension Act
oH.R. 4846/S.2538 Alternatives to Opioids in the Emergency Department Reauthorization Act
oH.R. 4970 Rural Medical Residency Expansion Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Beth |
Feldpush |
|
|
|
Carlos |
Jackson |
|
|
|
Margaret |
Peterson |
|
|
|
Carla "Nikki" |
Hurt |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |